Cardiorenal Outcomes with Ertugliflozin by Baseline Cardiorenal Medications: An Analysis from VERTIS CV

被引：0
|
作者：
Cherney, David
Cosentino, Francesco
Mcguire, Darren K.
Charbonnel, Bernard
Dagogo-Jack, Samuel
Pratley, Richard E.
Shih, Weichung J.
Maldonado, Mario
Pong, Annpey
Gantz, Ira
Frederich, Robert
Mancuso, James P.
Masiukiewicz, Urszula
Cannon, Christopher P.
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-796-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
796-P
引用
收藏
页数：4
相关论文
共 50 条
  • [41] A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes
    Lees, Jennifer S.
    Dobbin, Stephen J. H.
    Elyan, Benjamin M. P.
    Gilmour, David F.
    Tomlinson, Laurie P.
    Lang, Ninian N.
    Mark, Patrick B.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (07) : 1666 - 1681
  • [42] Cardiorenal outcomes with dapagliflozin by baseline glucose-lowering agents: Post hoc analyses fromDECLARE-TIMI58
    Cahn, Avivit
    Wiviott, Stephen D.
    Mosenzon, Ofri
    Murphy, Sabina A.
    Goodrich, Erica L.
    Yanuv, Ilan
    Rozenberg, Aliza
    Wilding, John P. H.
    Leiter, Lawrence A.
    Bhatt, Deepak L.
    McGuire, Darren K.
    Litwak, Leon
    Kooy, Adriaan
    Gause-Nilsson, Ingrid A. M.
    Fredriksson, Martin
    Langkilde, Anna Maria
    Sabatine, Marc S.
    Raz, Itamar
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (01): : 29 - 38
  • [43] HYPOGLYCEMIA AND CV OUTCOMES IN PARTICIPANTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: OBSERVATIONS FROM THE VERTIS CV TRIAL
    Pratley, Richard E.
    McGuire, Darren K.
    Fu, Wei
    Cannon, Christopher P.
    Cherney, David Z. I.
    Cosentino, Francesco
    Liu, Jie
    Frederich, Robert
    Mancuso, James P.
    Dagogo-Jack, Samuel
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2062 - 2062
  • [44] Mediation analyses of the effect of ertugliflozin on hospitalisation for heart failure in patients with type 2 diabetes and atherosclerotic cardiovascular disease from the VERTIS CV trial
    Segar, M. W.
    Pandey, A.
    Cherney, D. Z. I.
    Cannon, C. P.
    Cosentino, F.
    Dagogo-Jack, S.
    Pratley, R. E.
    Shih, W. J.
    Frederich, R.
    Cater, N. B.
    Maldonado, M.
    Liu, J.
    Liu, C.
    Pong, A.
    McGuire, D. K.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 2649 - 2649
  • [45] Frontier and Hotspot Evolution in Cardiorenal Syndrome: A Bibliometric Analysis From 2003 to 2022
    Lv, Jiayu
    Li, Yumeng
    Shi, Shuqing
    Liu, Shixu
    Xu, Xia
    Wu, Huaqin
    Zhang, Bingxuan
    Song, Qingqiao
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (08)
  • [46] Impact of microvascular disease on cardiorenal outcomes in type 2 diabetes: an analysis from the LEADER and SUSTAIN 6 clinical trials
    Zinman, B.
    Verma, S.
    Bain, S. C.
    Honore, J. B.
    Mann, J.
    Nauck, M. A.
    Pratley, R.
    Rasmussen, S.
    Ripa, M. Sejersten
    Buse, J. B.
    [J]. DIABETOLOGIA, 2019, 62 : S365 - S366
  • [47] Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Cherney, David Z., I
    McGuire, Darren K.
    Cosentino, Francesco
    Shih, Weichung J.
    Liu, Jie
    Frederich, Robert
    Mancuso, James P.
    Raji, Annaswamy
    Gantz, Ira
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [48] IMPACT OF MICROVASCULAR DISEASE ON CARDIORENAL OUTCOMES IN TYPE 2 DIABETES: AN ANALYSIS FROM THE LEADER AND SUSTAIN-6 CLINICAL TRIALS
    Verma, Subodh
    Bain, Stephen C.
    Honore, Julie Broe
    Mann, Johannes F. E.
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Ripa, Maria Sejersten
    Zinman, Bernard
    Buse, John
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1687 - 1687
  • [49] Cardiorenal Outcomes With Finerenone in Asian Patients With CKD and Type 2 Diabetes: Post Hoc Analysis From FIDELIO-DKD
    Koya, Daisuke
    Anker, Stefan D.
    Ruilope, Luis M.
    Rossing, Peter
    Lee, Byung-Wan
    Lee, Chien-Te
    Liu, Zhi Hong
    Scott, Charlie
    Kolkhof, Peter
    Lawatscheck, Robert
    Wang, Lili
    Joseph, Amer
    Pitt, Bertram
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 678 - 678
  • [50] Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CV
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Cherney, David
    Charbonnel, Bernard
    Mcguire, Darren K.
    Cosentino, Francesco
    Shih, Weichung J.
    Liu, Jie
    Frederich, Robert
    Mancuso, James P.
    Raji, Annaswamy
    Gantz, Ira
    [J]. DIABETES, 2021, 70
12345